Skip to content

Eupraxia Pharmaceuticals

US · EPRX #3732 by market cap
7.52 -0.26 -3.34%
Live - 5344 symbols - heartbeat 495s ago · 2026-10-08 09:55
Pre-market 8.05 +3.47%
After-hours 7.78 0.00%
Market cap
496.87M
P/B
4.88
EPS
-1.03
Reader sentiment Are you bullish or bearish on EPRX?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Stifel Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $25
    Market Newswire · 2026/9/24
  • Rating change
    H.C. Wainwright Keeps Their Buy Rating on Eupraxia Pharmaceuticals (EPRX)
    TipRanks · 2026/9/22
  • Rating change
    Cantor Fitzgerald Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $19
    Market Newswire · 2026/7/20
  • Rating change
    H.C. Wainwright Remains a Buy on Eupraxia Pharmaceuticals (EPRX)
    TipRanks · 2026/5/4
  • A Quick Look at Today's Ratings for Eupraxia Pharmaceuticals(EPRX.US), With a Forecast Between $11 to $16
    Market Newswire · 2026/10/1
  • Rating change
    Oppenheimer Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $17
    Market Newswire · 2026/6/26
  • Rating change
    Bloom Burton Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $14
    Market Newswire · 2026/2/24
  • Rating change
    Craig-Hallum Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $14
    Market Newswire · 2026/5/5
  • Wedbush Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $17
    Market Newswire · 2026/9/24
  • Rating change
    William Blair Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $14
    Market Newswire · 2026/3/23
  • Rating change
    William Blair Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating
    Market Newswire · 2026/8/27
  • Rating change
    Craig-Hallum Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating
    Market Newswire · 2026/1/23
  • Rating change
    LifeSci Capital Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $16
    Market Newswire · 2026/8/27
  • Wedbush Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $17
    Market Newswire · 2026/10/1
  • Rating change
    H.C. Wainwright Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Cuts Target Price to $11
    Market Newswire · 2026/3/17
  • Rating change
    A Quick Look at Today's Ratings for Eupraxia Pharmaceuticals(EPRX.US), With a Forecast Between $11 to $25
    Market Newswire · 2026/8/13
  • Rating change
    Oppenheimer Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $17
    Market Newswire · 2026/6/26
  • Bloom Burton Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $14
    Market Newswire · 2026/10/1
  • Rating change
    H.C. Wainwright Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $11
    Market Newswire · 2026/9/22
  • Rating change
    Stifel Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $25
    Market Newswire · 2026/5/21

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 09:55:38 · For reference only, not investment advice and not tailored to your situation.